Sensus Healthcare, Inc. (SRTS) Stock

Sensus Healthcare, Inc. is a prominent medical device company specializing in the manufacture and global distribution of radiation therapy devices for healthcare providers. The company focuses on utilizing superficial radiation therapy (SRT), a technology based on low-energy X-rays, across its diverse portfolio of treatment devices. Among its flagship offerings is the SRT-100, an advanced photon X-ray superficial radiotherapy system designed to serve as a non-surgical alternative for treating non-melanoma skin cancers like basal cell and squamous cell carcinomas. Additionally, it addresses other skin conditions such as keloids. The SRT-100 Vision, another innovative product from Sensus Healthcare, integrates sophisticated treatment planning capabilities tailored for SRT applications. It includes features like embedded high-frequency ultrasound imaging, volumetric tumor analysis, beam margins planning, and precise dosimetry parameters.

Innovation continues to drive Sensus Healthcare's product development strategy. The company also markets the SRT-100 Plus, offering enhanced capabilities and features to meet evolving clinical needs. Complementing its device offerings, Sensus Healthcare provides a Sentinel service program aimed at safeguarding and supporting the operational efficiency of its systems for customers. Moreover, the company extends its services with in-office laser rental options, reinforcing its commitment to comprehensive customer support and service excellence in the healthcare sector.

Established in 2010 and headquartered in Boca Raton, Florida, Sensus Healthcare, Inc. has established itself as a leader in the field of radiation therapy devices. With a focus on technological innovation and customer-centric solutions, Sensus Healthcare continues to expand its global footprint, addressing critical medical needs and advancing treatment options for various skin conditions through its cutting-edge SRT technologies.